DEA schedule
Is Trijardy XR a controlled substance?
Trijardy XR contains empagliflozin, linagliptin and metformin. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Trijardy XR (empagliflozin, linagliptin and metformin) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and empagliflozin, linagliptin and metformin is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Trijardy XR?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 4 prescription listings from 1 labelers, none with a DEA schedule |
| DEA controlled substances list | empagliflozin, linagliptin and metformin is not on the list |
Trijardy XR NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0597-0380 | Trijardy XR | tablet, extended release | 10 mg/1; 5 mg/1; 1000 mg/1 | Boehringer Ingelheim Pharmaceuticals, Inc. | None |
| 0597-0385 | Trijardy XR | tablet, extended release | 12.5 mg/1; 2.5 mg/1; 1000 mg/1 | Boehringer Ingelheim Pharmaceuticals, Inc. | None |
| 0597-0390 | Trijardy XR | tablet, extended release | 25 mg/1; 5 mg/1; 1000 mg/1 | Boehringer Ingelheim Pharmaceuticals, Inc. | None |
| 0597-0395 | Trijardy XR | tablet, extended release | 5 mg/1; 2.5 mg/1; 1000 mg/1 | Boehringer Ingelheim Pharmaceuticals, Inc. | None |
Questions
Is Trijardy XR a controlled substance?
No. Trijardy XR (empagliflozin, linagliptin and metformin) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and empagliflozin, linagliptin and metformin is not on the DEA controlled substances list.
Is Trijardy XR a narcotic?
No. Trijardy XR (empagliflozin, linagliptin and metformin) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Biguanide and Dipeptidyl Peptidase 4 Inhibitor and Sodium-Glucose Cotransporter 2 Inhibitor.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Trijardy XR
- What is Trijardy XR used for?FDA label uses
- Generic for Trijardy XRFDA Orange Book
- Biguanides listFDA drug class
- Dipeptidyl Peptidase 4 Inhibitors listFDA drug class
- Sodium-Glucose Cotransporter 2 Inhibitors listFDA drug class
- NDC 0597-0380Trijardy XR NDC record
- NDC 0597-0385Trijardy XR NDC record
- NDC 0597-0390Trijardy XR NDC record